FDA grants new valve-in-valve TAVR offering its breakthrough device designation

Retrieved on: 2024-01-23 22:18:55

Tags for this article:

Click the tags to see associated articles and topics

FDA grants new valve-in-valve TAVR offering its breakthrough device designation. View article details on hiswai:

Excerpt

Pi-Cardia, an Israel-based healthcare technology company, has received ... According to Pi-Cardia, ShortCut is the first medical device of its kind.

Article found on: cardiovascularbusiness.com